Technical Analysis for NXL - Nexalin Technology, Inc.

Grade Last Price % Change Price Change
A 3.16 26.91% 0.67
NXL closed up 26.91 percent on Friday, November 1, 2024, on 3.93 times normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.
1 Watcher
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Up

Date Alert Name Type % Chg
Golden Cross Bullish 0.00%
New 52 Week Closing High Bullish 0.00%
Pocket Pivot Bullish Swing Setup 0.00%
Volume Surge Other 0.00%
Wide Range Bar Range Expansion 0.00%
Parabolic Rise Strength 0.00%
Wide Bands Range Expansion 0.00%
Above Upper BB Strength 0.00%
Overbought Stochastic Strength 0.00%
Upper Bollinger Band Touch Strength 0.00%

   Recent Intraday Alerts

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health in the United States and China. It licenses and markets Nexalin Device, a non-invasive and drug-free therapy for the treatment of anxiety and insomnia. The company's Nexalin device emits a patented frequency-based waveform, which stimulates a positive response from the mid-brain structures associated with various mental health disorders. It also engages in the development of Generation 2, a medical device that is in clinical trials for the treatment of substance abuse issues related to opiates, chronic pain, Alzheimer's disease, and dementia. The company was incorporated in 2021 and is headquartered in Houston, Texas.
Classification

Sector: Healthcare
Industry: Medical Devices
Keywords: Neuroscience Alzheimer's Disease Mental Health Chronic Pain Dementia Psychiatric Diagnosis Psychiatry Insomnia Mental Disorder Neurostimulation Mental Health Disorders

Is NXL a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 4.05
52 Week Low 0.2528
Average Volume 1,586,219
200-Day Moving Average 1.06
50-Day Moving Average 1.07
20-Day Moving Average 1.53
10-Day Moving Average 2.18
Average True Range 0.39
RSI (14) 76.47
ADX 48.34
+DI 45.67
-DI 6.00
Chandelier Exit (Long, 3 ATRs) 2.24
Chandelier Exit (Short, 3 ATRs) 1.75
Upper Bollinger Bands 3.06
Lower Bollinger Band 0.00
Percent B (%b) 1.03
BandWidth 200.22
MACD Line 0.50
MACD Signal Line 0.34
MACD Histogram 0.1602
Fundamentals Value
Market Cap 23.03 Million
Num Shares 7.29 Million
EPS -0.64
Price-to-Earnings (P/E) Ratio -4.94
Price-to-Sales 17.28
Price-to-Book 0.68
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 4.50
Resistance 3 (R3) 4.43 3.91 4.27
Resistance 2 (R2) 3.91 3.57 3.95 4.20
Resistance 1 (R1) 3.54 3.36 3.73 3.61 4.12
Pivot Point 3.02 3.02 3.12 3.06 3.02
Support 1 (S1) 2.65 2.68 2.84 2.72 2.20
Support 2 (S2) 2.13 2.47 2.17 2.12
Support 3 (S3) 1.76 2.13 2.05
Support 4 (S4) 1.83